Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 114548
Gene Symbol: NLRP3
NLRP3
0.010 AlteredExpression disease BEFREE The expressions of NLRP3 and downstream cytokine IL-1β were consistently elevated in perilesional keratinocytes of vitiligo. 31756352 2020
Entrez Id: 79092
Gene Symbol: CARD14
CARD14
0.010 Biomarker disease BEFREE To assess the additive effect of PRP in the therapy of vitiligo on the results of the excimer laser. 31541597 2019
Entrez Id: 3600
Gene Symbol: IL15
IL15
0.010 Biomarker disease BEFREE Taken together, our results demonstrate that oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to the activation of CD8<sup>+</sup> T<sub>EMs</sub>, providing a novel mechanism by which oxidative stress initiates autoimmunity in vitiligo. 31078730 2019
Entrez Id: 7001
Gene Symbol: PRDX2
PRDX2
0.010 Biomarker disease BEFREE To assess the additive effect of PRP in the therapy of vitiligo on the results of the excimer laser. 31541597 2019
Entrez Id: 387700
Gene Symbol: SLC16A12
SLC16A12
0.010 Biomarker disease BEFREE CRT 2 months post-treatment was higher among subjects who developed vitiligo (<i>p</i>-value = 0.02). 31577462 2019
Entrez Id: 5621
Gene Symbol: PRNP
PRNP
0.010 Biomarker disease BEFREE To assess the additive effect of PRP in the therapy of vitiligo on the results of the excimer laser. 31541597 2019
Entrez Id: 23410
Gene Symbol: SIRT3
SIRT3
0.010 Biomarker disease BEFREE Given the prominent role of nicotinamide adenine dinucleotide (NAD<sup>+</sup>)-dependent deacetylase Sirtuin3 (SIRT3) in sustaining mitochondrial dynamics and homeostasis and that SIRT3 expression and activity can be influenced by oxidative stress-related signaling, we wondered whether SIRT3 could play an important role in vitiligo melanocyte degeneration by regulating mitochondrial dynamics. 31037127 2019
Entrez Id: 406947
Gene Symbol: MIR155
MIR155
0.010 Biomarker disease BEFREE MicroRNA‑155 (miR‑155) is known to contribute to the pathogenesis of vitiligo; however, the mechanism by which miR‑155 regulates the development of vitiligo remains unclear. 31485649 2019
Entrez Id: 10062
Gene Symbol: NR1H3
NR1H3
0.010 AlteredExpression disease BEFREE The aim of this study is to investigate keratinocytes' role in vitiligo pathogenesis through immunohistochemical expression of LXR-α in lesional, perilesional, and distant nonlesional vitiligo skin. 29937560 2019
Entrez Id: 3084
Gene Symbol: NRG1
NRG1
0.010 AlteredExpression disease BEFREE Expression of NRG1 was significantly less in lesional dermis of vitiligo patients as compared to nonlesional and healthy control dermis both at mRNA as well as protein level. 30074619 2019
Entrez Id: 22915
Gene Symbol: MMRN1
MMRN1
0.010 Biomarker disease BEFREE Focusing on this interplay, we have reviewed existing literature supporting evidence on cellular and functional alterations of surrounding epidermal keratinocytes, extracellular matrix (ECM) proteins and fibroblasts in the underlying dermal compartment that may contribute to melanocyte disappearance in vitiligo. 30582762 2019
Entrez Id: 125972
Gene Symbol: CALR3
CALR3
0.010 Biomarker disease BEFREE CRT 2 months post-treatment was higher among subjects who developed vitiligo (<i>p</i>-value = 0.02). 31577462 2019
Entrez Id: 51561
Gene Symbol: IL23A
IL23A
0.010 AlteredExpression disease BEFREE The aim of this study was to explore the mechanism underlying CO2 fractional laser treatment of vitiligo by detecting the levels of Th1 cytokines (IL-2 and IFN-γ), Th2 cytokines (IL-4 and IL-10), and Th17 cytokines (IL-17 and IL-23) in peripheral blood. 31172649 2019
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.010 GeneticVariation disease BEFREE The aim of this study was to evaluate the possible associations between the +405 G/C single nucleotide polymorphisms (SNP) of the VEGF gene (rs2010963) and vitiligo. 31135085 2019
Entrez Id: 6364
Gene Symbol: CCL20
CCL20
0.010 Biomarker disease BEFREE To investigate the potential role of CCL20 and the involvement of Th1/17 and Tc1/17 cells in the mechanism in vitiligo. 30655106 2019
Entrez Id: 722
Gene Symbol: C4BPA
C4BPA
0.010 Biomarker disease BEFREE To assess the additive effect of PRP in the therapy of vitiligo on the results of the excimer laser. 31541597 2019
Entrez Id: 4552
Gene Symbol: MTRR
MTRR
0.010 GeneticVariation disease BEFREE This is the first study reporting the correlation between the polymorphic status of MTHFR C677T, CBS I278T, and MTRR A66G and vitiligo. 30720153 2019
Entrez Id: 5617
Gene Symbol: PRL
PRL
0.010 Biomarker disease BEFREE Additionally, enrichment analysis suggested that targets of KBL on vitiligo were mainly clustered into multiple biological processes (associated with DNA translation, lymphocyte differentiation and activation, steroid biosynthesis, autoimmune and systemic inflammatory reaction, neuron apoptosis, and vitamin deficiency) and related pathways (TNF, JAK-STAT, ILs, TLRs, prolactin, and NF-<i>κ</i>B), indicating the underlying mechanisms of KBL on vitiligo. 31781265 2019
Entrez Id: 5609
Gene Symbol: MAP2K7
MAP2K7
0.010 Biomarker disease BEFREE Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy. 30939167 2019
Entrez Id: 54475
Gene Symbol: NLE1
NLE1
0.010 GeneticVariation disease BEFREE A similar experiment was performed using further homeopathic preparations sourced from kojic acid (KA), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>; HP), 6-biopterin (BP), and [Nle<sup>4</sup>, D-Phe<sup>7</sup>]-α-melanocyte-stimulating hormone (NLE), some of which are known to induce vitiligo or melano-destruction at physiological dose. 30836409 2019
Entrez Id: 5473
Gene Symbol: PPBP
PPBP
0.010 AlteredExpression disease BEFREE Among these metabolites and proteins, lysophosphatidylcholine, platelet-activating factor, sn-glycerol-3-phosphocholine, succinic acid, CXCL4 and CXCL7 were significantly elevated in the plasma of patients with vitiligo, while aspartate was downregulated. 30859585 2019
Entrez Id: 10058
Gene Symbol: ABCB6
ABCB6
0.010 Biomarker disease BEFREE To assess the additive effect of PRP in the therapy of vitiligo on the results of the excimer laser. 31541597 2019
Entrez Id: 203190
Gene Symbol: LGI3
LGI3
0.010 AlteredExpression disease BEFREE Results: Baseline LGI3 immunohistochemical studied parameters (expression, intensity, percentage and H score) were significantly lower in vitiligo cases than controls (p=0.003, 0.013, 0.001 and 0.001 respectively). 31644616 2019
Entrez Id: 3303
Gene Symbol: HSPA1A
HSPA1A
0.010 Biomarker disease BEFREE HSP70i is secreted by stressed melanocytes, is associated with human vitiligo lesions, and functionally contributes to a mouse model of vitiligo.Henning et al. report that treatment with a modified version of the protein reversed depigmentation in Sinclair swine, a useful animal model of vitiligo. 30466536 2018
Entrez Id: 9588
Gene Symbol: PRDX6
PRDX6
0.010 AlteredExpression disease BEFREE The western blotting results showed that Peroxiredoxin‑6, apolipoprotein L1, apolipoprotein E and mannose‑binding protein were differentially expressed in patients with different stages of vitiligo. 29207142 2018